| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.004 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.005 |